(Q54251660)

26 May 2018

title

The new fluorinated quinolones for antimicrobial prophylaxis in neutropenic cancer patients. (English)

1 reference

26 May 2018

0 references

A Del Favero

1

1 reference

26 May 2018

F Menichetti

series ordinal

2

1 reference

26 May 2018

publication date

1 January 1993

1 reference

26 May 2018

European Journal of Cancer

published in

1 reference

26 May 2018

volume

29A Suppl 1

1 reference

26 May 2018

page(s)

S2-6

1 reference

26 May 2018

Antimicrobial prophylaxis against infection in neutropenic patients

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980252-7

7 January 2021

Infection prevention during profound granulocytopenia. New approaches to alimentary canal microbial suppression

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980252-7

7 January 2021

Symposium on infectious complications of neoplastic disease (Part II). Chemoprophylaxis of bacterial infections in granulocytopenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980252-7

7 January 2021

Cotrimoxazole Prophylaxis in Patients With Leukemia and Prolonged Granulocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980252-7

7 January 2021

Antimicrobial prophylaxis in the neutropenic host: lessons of the past and perspectives for the future

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980252-7

7 January 2021

The new fluorinated quinolones for infection prevention in acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980252-7

7 January 2021

Fluoroquinolone antimicrobial agents

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980252-7

7 January 2021

Colonization resistance of the digestive tract of mice during systemic antibiotic treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980252-7

7 January 2021

Colonization resistance of the human intestinal microflora: testing the hypothesis in normal volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980252-7

7 January 2021

Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980252-7

7 January 2021

Antimicrobial prophylaxis in immunocompromised patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980252-7

7 January 2021

Norfloxacin versus vancomycin/polymyxin for prevention of infections in granulocytopenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980252-7

7 January 2021

Ofloxacin versus vancomycin/polymyxin for prevention of infections in granulocytopenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980252-7

7 January 2021

Comparison of norfloxacin with cotrimoxazole for infection prophylaxis in acute leukemia. The trade-off for reduced gram-negative sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980252-7

7 January 2021

Prophylactic co-trimoxazole versus norfloxacin in neutropenic children--perspective randomized study.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980252-7

7 January 2021

Ofloxacin versus co-trimoxazole for prevention of infection in neutropenic patients following cytotoxic chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980252-7

7 January 2021

Infection prophylaxis in acute leukemia: a comparison of ciprofloxacin with trimethoprim-sulfamethoxazole and colistin.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980252-7

7 January 2021

Ciprofloxacin and norfloxacin for selective decontamination in patients with severe granulocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980252-7

7 January 2021

In vitro activities of vancomycin and teicoplanin against coagulase-negative staphylococci isolated from neutropenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980252-7

7 January 2021

Plasmid-mediated 4-quinolone resistance: a real or apparent absence?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980252-7

7 January 2021

Emerging resistance to fluoroquinolones in staphylococci: an alert

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980252-7

7 January 2021

Ciprofloxacin for selective decontamination of the alimentary tract in patients with acute leukemia during remission induction treatment: the effect on fecal flora

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980252-7

7 January 2021

Emergence of ciprofloxacin-resistant coagulase-negative staphylococcal skin flora in immunocompromised patients receiving ciprofloxacin.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980252-7

7 January 2021

Outbreak of coagulase negative staphylococcus highly resistant to ciprofloxacin in a leukaemia unit

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980252-7

7 January 2021

10.1016/S0959-8049(05)80252-7

Identifiers

DOI

1 reference

26 May 2018

1 reference

26 May 2018